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Reelin is a neurodevelopmental protein important in adult synaptic plasticity and learning
and memory. Recent evidence points to the importance for Reelin proteolysis in normal
signaling and in cognitive function. Support for the dysfunction of Reelin proteolysis
in neurodegeneration and cognitive dysfunction comes from postmortem analysis of
Alzheimer’s diseases (AD) tissues including cerebral spinal fluid (CSF), showing that
levels of Reelin fragments are altered in AD compared to control. Potential key proteases
involved in Reelin proteolysis have recently been defined, identifying processes that could
be altered in neurodegeneration. Introduction of full-length Reelin and its proteolytic
fragments into several mouse models of neurodegeneration and neuropsychiatric
disorders quickly promote learning and memory. These findings support a role for Reelin
in learning and memory and suggest further understanding of these processes are
important to harness the potential of this pathway in treating cognitive symptoms in
neuropsychiatric and neurodegenerative diseases.
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Neurodegenerative diseases are characterized by the progressive loss of synapses and neurons,
accounting for cognitive deterioration. One molecular pathway that is well characterized in
playing a role in adult synaptic plasticity and learning and memory is the Reelin signaling
pathway (Weeber et al., 2002; Chen et al., 2005; Qiu et al., 2006a,b; Qiu and Weeber,
2007; Rogers et al., 2011). Reelin is also involved in a number of neurodegenerative and
neuropsychiatric disorders presenting with cognitive deficits, including schizophrenia (Guidotti
et al., 2000; Chen et al., 2002; Fatemi, 2005; Torrey et al., 2005), bipolar disorder (Fatemi
et al., 2000; Torrey et al., 2005), depression (Knable et al., 2004; Lussier et al., 2009, 2011,
2013a,b; Fenton et al., 2015), epilepsy (Fournier et al., 2010; Haas and Frotscher, 2010; Dutta
et al., 2011) and autism (Fatemi et al., 2005). Furthermore, Reelin signal transduction pathways
appear to be particularly vulnerable in Alzheimer’s disease (AD), potentially contributing to
its pathogenesis (Hoe et al., 2006; Hoareau et al., 2008). Thus, a better understanding of
Reelin signaling could be useful in developing therapies against synaptic and neuronal loss
in a number of conditions.
REELIN IN DEVELOPMENT
Reelin is an extracellular matrix protein important in brain development during embryogenesis
(for detailed reviews, see Lambert de Rouvroit et al., 1999; Rice and Curran, 2001; Tissir
and Goffinet, 2003). During development Reelin is expressed by Cajal–Retzius cells
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in the hippocampus and cortex and granule cells in the
cerebellum (Ogawa et al., 1995; Del Río et al., 1997; Frotscher,
1998; Hirota et al., 2015). In the adult brain GABAergic
interneurons in the cortex and hippocampus secrete Reelin
(Alcantara et al., 1998; Pesold et al., 1998). Much of what we
know about the Reelin signaling pathway in development comes
from mouse models that have knock-down or overexpression of
critical proteins in the pathway: Reelin, lipoprotein receptors,
and Disabled-1 (Dab1; Howell et al., 1997b; Hiesberger et al.,
1999; Trommsdorff et al., 1999; Beffert et al., 2002; Drakew et al.,
2002; Weeber et al., 2002; Qiu et al., 2006a; Pujadas et al., 2010,
2014; Teixeira et al., 2011; Trotter et al., 2013; Lane-Donovan
et al., 2015).
REELIN SIGNALING PATHWAY
Once Reelin is secreted by GABAergic interneurons into the
extracellular space it binds to the lipoprotein receptors, very-
low-density lipoprotein receptor (VLDLR) and Apolipoprotein
receptor 2 (ApoER2; D’Arcangelo et al., 1999; Weeber et al.,
2002; Herz and Chen, 2006; Figure 1). Ligand interactions
lead to receptor dimerization and tyrosine phosphorylation of
the downstream intracellular adaptor protein Dab1 (Howell
et al., 1997a; D’Arcangelo et al., 1999; Hiesberger et al., 1999;
Strasser et al., 2004; Herz and Chen, 2006; Trotter et al., 2013,
2014; Divekar et al., 2014). Dab1 phosphorylation activates Src
family tyrosine kinases (SFK), such as Fyn, which phosphorylates
N-methyl-D-aspartate (NMDA) receptors allowing increases in
Ca2+ influx (Chen et al., 2005). Enhancement in Ca2+ influx
allows for maturation of NMDA receptors from the NR2B
to NR2A receptor subtype, increased membrane α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor
insertion, and can contribute to the induction and enhancement
of long-term potentiation (LTP; Weeber et al., 2002; Beffert
et al., 2005; Chen et al., 2005; Herz and Chen, 2006; Qiu
et al., 2006b; Qiu and Weeber, 2007). In addition, Dab1-induced
phosphorylation also can activate Phosphatidylinositol-3-kinase
(PI3K) and protein kinase B (PKB/Akt) which then causes
Glycogen synthase kinase 3 beta (GSK3β) inhibition (Beffert
et al., 2002), in turn suppressing tau hyperphosphorylation
(Ohkubo et al., 2003).
As Reelin positive cells are found in highest numbers in the
CA1 stratum lacunosum and hilus, they are in prime locations to
influence learning and memory, and neurogenesis, respectively.
Indeed, Reelin has been shown to enhance synaptic plasticity and
learning and memory (Weeber et al., 2002; Herz and Chen, 2006;
Rogers andWeeber, 2008), as well as altermigration of adult born
neurons (Zhao et al., 2007; Pujadas et al., 2010; Teixeira et al.,
2012). In the hippocampus, extracellular Reelin accumulates
in the stratum lacunosum (Pesold et al., 1999; Lussier et al.,
2009) which makes it in a prime location to influence synaptic
activity in the CA1 (Weeber et al., 2002; Herz and Chen, 2006;
FIGURE 1 | Reelin signaling pathway in adult synaptic plasticity. Reelin binds to the lipoprotein receptors apolipoprotein receptor 2 (ApoER2) and
very-low-density lipoprotein receptor (VLDLR) which causes receptor clustering and the src family tyrosine kinases (SFK) tyrosine phosphorylation of the intracellular
adaptor protein Disabled-1 (Dab1), which results in the phosphorylation of N-methyl-D-aspartate receptor (NMDAR; D’Arcangelo et al., 1997, 1999; Weeber et al.,
2002; Niu et al., 2004; Beffert et al., 2005; Chen et al., 2005; Qiu et al., 2006b; Qiu and Weeber, 2007; Burrell et al., 2014; Divekar et al., 2014). A subsequent
increase in calcium influx leads to depolarization of the post-synaptic membrane and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)
insertion (Weeber et al., 2002; Qiu et al., 2006b; Qiu and Weeber, 2007). A consequence of the increase in Ca2+ influx and depolarization of the cell is increased
CREB phosphorylation and protein synthesis, which ultimately results in increased synaptic plasticity and learning and memory (Niu et al., 2008; Rogers et al., 2011,
2013). Another result of Dab1 phosphorylation is activation of phosphatidylinositol-3-kinase (PI3K), protein kinase B (PKB/Akt), and modulation of Glycogen synthase
kinase 3 beta (GSK3β), which inhibits Tau phosphorylation (Beffert et al., 2002). Phosphorylation of Dab1 also regulates the conversion of p35 to p25 and results in
activation of CDK5, also responsible for Tau phosphorylation (Beffert et al., 2004).
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Rogers and Weeber, 2008). Endogenous cleavage of Reelin in
these regions may be used to regulate Reelin’s effects on these
processes.
REELIN PROCESSING
Reelin signaling may not be driven by the simple production
and release of Reelin from interneurons, as with neuropeptides
or small molecule transmitters, but it may be regulated by
the directed proteolysis of sequestered, full length, extracellular
Reelin. Reelin has been shown to have two main sites of
cleavage, between EGF-like repeats 2–3 (R2–3) and repeats
6–7 (R6–7; Jossin et al., 2004; Figure 2). These cleavage
sites result in five major fragments that can be found in
the adult and developing brain (Jossin et al., 2007; Krstic
et al., 2012; Trotter et al., 2014). The middle R3–6 fragment
interacts with the VLDLR and ApoER2 and is considered
the fragment that is involved in initiating the downstream
signaling of the Reelin cascade (Jossin et al., 2004). Our
laboratory (Trotter et al., 2014) and others (Nagy et al.,
2006; Nogi et al., 2006; Nakano et al., 2007; Hisanaga
et al., 2012; Krstic et al., 2012) have attempted to identify
Reelin-cleaving enzymes, such as the serine protease tissue
plasminogen activator (tPA), matrix metalloproteinases (MMP),
and a disintegrin and metalloproteinase with thrombospondin
motifs (ADAMTS), and the functional role of this proteolytic
processing.
We have recently identified one mechanism for the normal
processing of extracellular Reelin, through the effects of the
serine protease tPA in the brain (Trotter et al., 2014). The
activity-dependent proteolysis of Reelin between R6 and R7
in wild-type mice was not seen in tPA KO mice, supporting
FIGURE 2 | Reelin proteolysis in the adult brain. (A) Full length Reelin is released into the extracellular space by GABAergic interneurons in the adult brain.
This full length Reelin is enzymatically cleaved between epidermal growth factor (EGF) repeats 2–3 (R2-R3) and 6–7 (R6-R7; indicated by dotted lines; A,B), by a
number of different enzymes. For example, tissue plasminogen activator (tPA), Meprin α and β have been shown to cleave Reelin between R6 and R7 (Kohno et al.,
2009; Krstic et al., 2012; Trotter et al., 2014; Sato et al., 2016), while matrix metalloproteinases (MMP)-9 cleaves Reelin between R2 and R3 (Krstic et al., 2012). The
ADAMTS 4 and 5 have been shown to cleave Reelin at both sites (Hisanaga et al., 2012; Krstic et al., 2012). Other, yet to be identified proteases, are also potentially
involved in Reelin processing. (B) Full length Reelin (450 kDa) is cleaved by a number of enzymes which result in the production of five fragments that range from
370–80 kDa. The R3-R6 fragment [included in the full length Reelin (450 kDa), 370 kDa, 190 kDa, and 270 kDa fragments] has been shown to bind to the lipoprotein
receptors, ApoER2 and VLDLR (Jossin et al., 2004). The N-R2 fragment (180 kDa) has been shown to bind to alpha3beta1-integrins (Dulabon et al., 2000) and
neuronal migration has been shown to be disrupted in vivo by the CR-50 antibody (Nakajima et al., 1997). The C-terminal region (R7-C; 80 kDa) has been shown to
be involved the secretion of Reelin, as well as its proper folding (de Bergeyck et al., 1997; Jossin et al., 2004), and for downstream signaling efficacy
(Nakano et al., 2007).
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a role of this protease in NMDAR-independent LTP induced
cleavage of Reelin (Trotter et al., 2014). In cell culture,
Reelin cleavage between R6–7 by tPA was blocked by serpin
E1 inhibitor (Krstic et al., 2012). Our cell-free conditions
in which we incubated tPA with Reelin for 45 min also
produced increased the N-R6 fragment (370 kDa), which was
blocked with Plasminogen activator inhibitor (PAI-1; serpin E1)
and diisoporpyl fluorophosphates (a serine protease inhibitor),
but not blocked by Aprotinin or CR-50 (an antibody that
binds in the N-terminal region of Reelin; D’Arcangelo et al.,
1997; Trotter et al., 2014). Similarly, metalloproteases meprin
α and β cleave Reelin between the R6 and R7 repeats (Sato
et al., 2016). However, neither tPA knock-out mice (Trotter
et al., 2014) nor meprin β knock-out mice (Sato et al., 2016)
demonstrate differences in basal levels of full length Reelin
or Reelin fragments, suggesting that combinations of proteases
are involved in constitutive Reelin levels and proteolysis.
Furthermore, Reelin proteolysis may be important in activity-
dependent or pathological conditions.
Much of what is known about signaling abilities of specific
Reelin domains comes from research on the canonical Reelin-
lipoprotein-Dab1 pathway (Figure 1). In support of the
importance of the middle R3–6 fragment in lipoprotein receptor
binding, cleavage within the R3 repeat has recently been shown
to decrease Dab1 phosphorylation (Kohno et al., 2009; Koie
et al., 2014). However, the other fragments have also been
suggested to be vital for normal Reelin signaling. For example,
the N-R2 fragment has been shown to bind to alpha3beta1-
integrins (Dulabon et al., 2000) and the CR-50 antibody can
disrupt in vivo neuronal migration (Nakajima et al., 1997).
The C-terminal region (R7-C) has been suggested to be involved
in Reelin secretion, folding (de Bergeyck et al., 1997; Jossin et al.,
2004), and signaling efficacy (Nakano et al., 2007), although
no known receptors have been identified for R7-C binding.
Recently, Kohno et al. (2015), have shown that the C-terminal
region is critical in postnatal cerebral cortex development but
not in embryonic stages. Further research is needed to fully




Support for the role of Reelin proteolysis in human disease
has been found in both neuropsychiatric and neurodegenerative
disorders. For example, the N-R2 fragment is increased in AD
and frontotemporal dementia patients when compared to non-
demented patients (Sáez-Valero et al., 2003; Botella-López et al.,
2006). In patients with confirmed diagnosis for depression and
bipolar disorder, the N-R2 fragment is found to be decreased
in blood samples, while for schizophrenia patients the N-R6
fragment is increased (Fatemi et al., 2001). Reelin may also play
a role in seizure control: epilepsy models have altered Reelin
processing (Tinnes et al., 2011, 2013; Kaneko et al., 2016), which
may be MMP-dependent. These differences in Reelin fragment
levels point to an importance in Reelin levels and proteolytic
dysfunction in disease states.
REELIN AND AD PATHOETIOLOGY
In AD, loss of synapses and neurons is accompanied
neuropathologically by amyloid deposits composed of the
Amyloid beta (Aβ) peptide, and neurofibrillary tangles composed
of modified versions of the tau protein (Trojanowski and Lee,
2002; Schellenberg and Montine, 2012; Sheng et al., 2012).
Exogenous Aβ application and endogenous Aβ aggregates
block various forms of synaptic plasticity and inhibit memory
formation and retrieval (Klyubin et al., 2005; Selkoe, 2008;
Talantova et al., 2013). Hyperphosphorylated forms of tau
are also associated with the disruption of synaptic plasticity,
learning and memory (Trojanowski and Lee, 2002; Santacruz
et al., 2005; Lasagna-Reeves et al., 2011, 2012; Shipton et al.,
2011). Altered Reelin signaling has been linked to AD through
analyses of human brain samples (Herring et al., 2012; Notter
and Knuesel, 2013), and animal models connecting Reelin
to the processes of amyloid accumulation (Chin et al., 2007;
Kocherhans et al., 2010; Pujadas et al., 2014) and to tau
phosphorylation (Ohkubo et al., 2003; Herz and Chen, 2006;
Kocherhans et al., 2010; Cuchillo-Ibáñez et al., 2013). In
addition, Reelin signaling has been associated with human
AD synaptic dysfunction in a non-targeted transcriptomic
approach (Karim et al., 2014), and the Reelin gene was associated
with AD pathological findings in elderly controls in a non-
targeted genomic approach (Kramer et al., 2011). Finally, two
of the strongest genetic risk factors for AD, Apolipoprotein E
(APOE) and clusterin (APOJ), encode proteins that bind to
the Reelin receptors (Reddy et al., 2011; Tapia-González et al.,
2011).
These lines of research have led to the investigation of
possible mechanisms for how Reelin could specifically affect
AD. Reelin may modify amyloid levels by directly interacting
with amyloid precursor protein (APP; Hoe et al., 2009)
or altering APP metabolism to decrease the generation Aβ
(Rice et al., 2013; Pujadas et al., 2014). Reelin also causes
GSK3β inhibition (Beffert et al., 2002), which suppresses tau
hyperphosphorylation (Ohkubo et al., 2003). In mouse models of
AD, overexpressing Reelin prevented AD pathological changes
(Pujadas et al., 2014), and lowering levels of Reelin accelerated
Aβ deposition and the synaptic dysfunction caused by the
presence of amyloid (Kocherhans et al., 2010; Lane-Donovan
et al., 2015). In addition to these effects on the neuropathologic
accumulations in AD brain, several lines of evidence suggest
that Reelin and Aβ have antagonistic effects on neuronal
survival and signaling. These findings include reduction of
Reelin and Reelin signaling in an AD mouse model (Mota
et al., 2014), electrophysiological measures of Reelin and Aβ
effects on hippocampal brain slices (Durakoglugil et al., 2009),
and behavioral studies in AD mouse models with altered
levels of Reelin (Pujadas et al., 2010; Lane-Donovan et al.,
2015).
REELIN AS A THERAPEUTIC TARGET
As mentioned above, different Reelin fragments are altered in
neuropsychiatric and degenerative diseases. These alterations
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may be an indication of disruption in Reelin processing and
may be useful in identifying biomarkers for disease states.
Reelin has been shown to be sequestered by Aβ plaques in
an age-dependent manner (Knuesel et al., 2009; Doehner and
Knuesel, 2010; Kocherhans et al., 2010; Stranahan et al., 2011).
Removal of Reelin from the synapse can alter many Reelin-
dependent functions, causing abnormal cellular migration,
dendritic morphology atrophy and deficits in synaptic plasticity
(Herz and Chen, 2006; Rogers and Weeber, 2008; Bu, 2009).
Given the progressive memory decline seen in AD patients,
it is possible that the sequestering of Reelin by the amyloid
plaques can alter its normal regulation via cleavage mechanisms
and its normal enhancement of learning and memory. It
is interesting to note that crossing a transgenic mouse that
overexpresses Reelin with an AD mouse model protects from
amyloid plaque formation and rescues learning and memory
deficits when compared to the AD mice (Pujadas et al.,
2014), while decreasing Reelin in AD models accelerates plaque
formation and increases tau hyperphosphorylation (Kocherhans
et al., 2010). Interestingly, a novel inducible Reelin knockout
mouse line has revealed that adult knockdown of Reelin
expression results in no discernable differences in normal
learning and memory and actually enhances late LTP (Lane-
Donovan et al., 2015). When these Reelin knockdown mice
were crossed with Tg2576 AD mice they did not cause an
increase Aβ pathology; however, these mice showed poorer
learning in the hidden platform water maze and deficits in the
24 h probe test when compared to controls (Lane-Donovan
et al., 2015). These results support the importance of Reelin
signaling in normal cognitive function and shows that a loss
of Reelin signaling in an AD mouse model increases cognitive
dysfunction.
Introduction of exogenous Reelin into the brain can
have surprisingly profound effects on synaptic plasticity and
cognition. Hippocampal injection(s) of Reelin and its fragments
has demonstrated significant improvements in models of
Reelin deficiency (Rogers et al., 2013), Angelman syndrome
(Hethorn et al., 2015), and schizophrenia (Ishii et al., 2015).
Remarkably, exogenous Reelin also enhanced learning and
memory as well as increased synaptic plasticity in wild-type
mice (Rogers et al., 2011). Thus, therapeutic approaches to
promoting Reelin signaling could be useful in protecting synapse
function and survival in a range of disorders. This work would
require a better understanding of which domains of Reelin
are necessary for the regulated Reelin signaling, and assays
for examining whether new Reelin-based therapies promote
receptor clustering, intracellular signaling, synapse stabilization,
and neuronal protection. Althoughmore work is required to fully
understand the function of each of these Reelin fragments, the
current research points to a therapeutic potential for altering
specific Reelin fragments in treating neuronal dysfunction and
cognitive deficits in neurodegenerative and neuropsychiatric
disorders.
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